{"id":"https://openalex.org/W2592300534","doi":"https://doi.org/10.1097/yic.0000000000000168","title":"Reduced sexual dysfunction with aripiprazole once-monthly versus paliperidone palmitate","display_name":"Reduced sexual dysfunction with aripiprazole once-monthly versus paliperidone palmitate","publication_year":2017,"publication_date":"2017-03-02","ids":{"openalex":"https://openalex.org/W2592300534","doi":"https://doi.org/10.1097/yic.0000000000000168","mag":"2592300534","pmid":"https://pubmed.ncbi.nlm.nih.gov/28252452","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5378005"},"language":"en","primary_location":{"id":"doi:10.1097/yic.0000000000000168","doi":"https://doi.org/10.1097/yic.0000000000000168","is_oa":true,"landing_page_url":"https://doi.org/10.1097/yic.0000000000000168","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1097/yic.0000000000000168","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050834331","display_name":"Steven G. Potkin","orcid":"https://orcid.org/0000-0003-1028-1013","observed_orcids":["https://orcid.org/0000-0003-1028-1013"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]},{"id":"https://openalex.org/I4210108711","display_name":"University Medical Center Hamburg-Eppendorf","ror":"https://ror.org/01zgy1s35","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I159176309","https://openalex.org/I4210108711"]},{"id":"https://openalex.org/I4405268153","display_name":"Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)","ror":"https://ror.org/001nxvg84","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268153"]}],"countries":["DE","US"],"is_corresponding":true,"raw_author_name":"Steven G. Potkin","raw_affiliation_strings":["aDepartment of Psychiatry and Human Behavior, University of California, Irvine, California bLundbeck LLC, Paramus, New Jersey cOtsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey dLundbeck LLC, Deerfield, Illinois, USA eOtsuka Pharmaceutical Europe Ltd., Wexham, UK fLundbeck SAS Issy-les-Moulineaux, Paris, France gH. Lundbeck A/S, Valby, Denmark hDepartment for Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany","Accepted January 17, 2017; Received July 11, 2016; This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/; aDepartment of Psychiatry and Human Behavior, University of California, Irvine, California; bLundbeck LLC, Paramus, New Jersey; cOtsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey; dLundbeck LLC, Deerfield, Illinois, USA; e-mail: [email\u00a0protected]; eOtsuka Pharmaceutical Europe Ltd., Wexham, UK; fLundbeck SAS Issy-les-Moulineaux, Paris, France; fax: +1 949 824 3324; gH. Lundbeck A/S, Valby, Denmark; hDepartment for Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"aDepartment of Psychiatry and Human Behavior, University of California, Irvine, California bLundbeck LLC, Paramus, New Jersey cOtsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey dLundbeck LLC, Deerfield, Illinois, USA eOtsuka Pharmaceutical Europe Ltd., Wexham, UK fLundbeck SAS Issy-les-Moulineaux, Paris, France gH. Lundbeck A/S, Valby, Denmark hDepartment for Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany","institution_ids":["https://openalex.org/I204250578","https://openalex.org/I4210108711","https://openalex.org/I4405268153"]},{"raw_affiliation_string":"Accepted January 17, 2017; Received July 11, 2016; This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/; aDepartment of Psychiatry and Human Behavior, University of California, Irvine, California; bLundbeck LLC, Paramus, New Jersey; cOtsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey; dLundbeck LLC, Deerfield, Illinois, USA; e-mail: [email\u00a0protected]; eOtsuka Pharmaceutical Europe Ltd., Wexham, UK; fLundbeck SAS Issy-les-Moulineaux, Paris, France; fax: +1 949 824 3324; gH. Lundbeck A/S, Valby, Denmark; hDepartment for Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109405045","display_name":"J.-Y. Loze","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]},{"id":"https://openalex.org/I4210156418","display_name":"Otsuka (United Kingdom)","ror":"https://ror.org/04bx2zy40","country_code":"GB","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4210156418"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"Jean-Yves Loze","raw_affiliation_strings":["Otsuka Pharmaceutical Europe Ltd., Wexham, UK","Accepted January 17, 2017; Received July 11, 2016; This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/; aDepartment of Psychiatry and Human Behavior, University of California, Irvine, California; bLundbeck LLC, Paramus, New Jersey; cOtsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey; dLundbeck LLC, Deerfield, Illinois, USA; e-mail: [email\u00a0protected]; eOtsuka Pharmaceutical Europe Ltd., Wexham, UK; fLundbeck SAS Issy-les-Moulineaux, Paris, France; fax: +1 949 824 3324; gH. Lundbeck A/S, Valby, Denmark; hDepartment for Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otsuka Pharmaceutical Europe Ltd., Wexham, UK","institution_ids":["https://openalex.org/I4210156418"]},{"raw_affiliation_string":"Accepted January 17, 2017; Received July 11, 2016; This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/; aDepartment of Psychiatry and Human Behavior, University of California, Irvine, California; bLundbeck LLC, Paramus, New Jersey; cOtsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey; dLundbeck LLC, Deerfield, Illinois, USA; e-mail: [email\u00a0protected]; eOtsuka Pharmaceutical Europe Ltd., Wexham, UK; fLundbeck SAS Issy-les-Moulineaux, Paris, France; fax: +1 949 824 3324; gH. Lundbeck A/S, Valby, Denmark; hDepartment for Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017509027","display_name":"Carlos Forray","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carlos Forray","raw_affiliation_strings":["Lundbeck LLC, Paramus, New Jersey","Accepted January 17, 2017; Received July 11, 2016; This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/; aDepartment of Psychiatry and Human Behavior, University of California, Irvine, California; bLundbeck LLC, Paramus, New Jersey; cOtsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey; dLundbeck LLC, Deerfield, Illinois, USA; e-mail: [email\u00a0protected]; eOtsuka Pharmaceutical Europe Ltd., Wexham, UK; fLundbeck SAS Issy-les-Moulineaux, Paris, France; fax: +1 949 824 3324; gH. Lundbeck A/S, Valby, Denmark; hDepartment for Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lundbeck LLC, Paramus, New Jersey","institution_ids":[]},{"raw_affiliation_string":"Accepted January 17, 2017; Received July 11, 2016; This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/; aDepartment of Psychiatry and Human Behavior, University of California, Irvine, California; bLundbeck LLC, Paramus, New Jersey; cOtsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey; dLundbeck LLC, Deerfield, Illinois, USA; e-mail: [email\u00a0protected]; eOtsuka Pharmaceutical Europe Ltd., Wexham, UK; fLundbeck SAS Issy-les-Moulineaux, Paris, France; fax: +1 949 824 3324; gH. Lundbeck A/S, Valby, Denmark; hDepartment for Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071947762","display_name":"Ross A. Baker","orcid":"https://orcid.org/0000-0001-5256-0470","observed_orcids":["https://orcid.org/0000-0001-5256-0470"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]},{"id":"https://openalex.org/I4210086062","display_name":"Otsuka (United States)","ror":"https://ror.org/00ew4na22","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4210086062"]},{"id":"https://openalex.org/I4405268153","display_name":"Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)","ror":"https://ror.org/001nxvg84","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ross A. Baker","raw_affiliation_strings":["Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey","Accepted January 17, 2017; Received July 11, 2016; This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/; aDepartment of Psychiatry and Human Behavior, University of California, Irvine, California; bLundbeck LLC, Paramus, New Jersey; cOtsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey; dLundbeck LLC, Deerfield, Illinois, USA; e-mail: [email\u00a0protected]; eOtsuka Pharmaceutical Europe Ltd., Wexham, UK; fLundbeck SAS Issy-les-Moulineaux, Paris, France; fax: +1 949 824 3324; gH. Lundbeck A/S, Valby, Denmark; hDepartment for Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey","institution_ids":["https://openalex.org/I4210086062","https://openalex.org/I4405268153"]},{"raw_affiliation_string":"Accepted January 17, 2017; Received July 11, 2016; This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/; aDepartment of Psychiatry and Human Behavior, University of California, Irvine, California; bLundbeck LLC, Paramus, New Jersey; cOtsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey; dLundbeck LLC, Deerfield, Illinois, USA; e-mail: [email\u00a0protected]; eOtsuka Pharmaceutical Europe Ltd., Wexham, UK; fLundbeck SAS Issy-les-Moulineaux, Paris, France; fax: +1 949 824 3324; gH. Lundbeck A/S, Valby, Denmark; hDepartment for Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034727243","display_name":"Christophe Sapin","orcid":"https://orcid.org/0000-0001-7655-7129","observed_orcids":["https://orcid.org/0000-0001-7655-7129"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]},{"id":"https://openalex.org/I2800004676","display_name":"Observatoire de Paris","ror":"https://ror.org/029nkcm90","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I2746051580","https://openalex.org/I2800004676"]}],"countries":["FR","US"],"is_corresponding":false,"raw_author_name":"Christophe Sapin","raw_affiliation_strings":["Lundbeck SAS Issy-les-Moulineaux, Paris, France","Accepted January 17, 2017; Received July 11, 2016; This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/; aDepartment of Psychiatry and Human Behavior, University of California, Irvine, California; bLundbeck LLC, Paramus, New Jersey; cOtsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey; dLundbeck LLC, Deerfield, Illinois, USA; e-mail: [email\u00a0protected]; eOtsuka Pharmaceutical Europe Ltd., Wexham, UK; fLundbeck SAS Issy-les-Moulineaux, Paris, France; fax: +1 949 824 3324; gH. Lundbeck A/S, Valby, Denmark; hDepartment for Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lundbeck SAS Issy-les-Moulineaux, Paris, France","institution_ids":["https://openalex.org/I2800004676"]},{"raw_affiliation_string":"Accepted January 17, 2017; Received July 11, 2016; This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/; aDepartment of Psychiatry and Human Behavior, University of California, Irvine, California; bLundbeck LLC, Paramus, New Jersey; cOtsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey; dLundbeck LLC, Deerfield, Illinois, USA; e-mail: [email\u00a0protected]; eOtsuka Pharmaceutical Europe Ltd., Wexham, UK; fLundbeck SAS Issy-les-Moulineaux, Paris, France; fax: +1 949 824 3324; gH. Lundbeck A/S, Valby, Denmark; hDepartment for Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019589345","display_name":"Timothy S. Peters-Strickland","orcid":"https://orcid.org/0000-0001-9985-6711","observed_orcids":["https://orcid.org/0000-0001-9985-6711"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]},{"id":"https://openalex.org/I4210086062","display_name":"Otsuka (United States)","ror":"https://ror.org/00ew4na22","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4210086062"]},{"id":"https://openalex.org/I4405268153","display_name":"Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)","ror":"https://ror.org/001nxvg84","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268153"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy Peters-Strickland","raw_affiliation_strings":["Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey","Accepted January 17, 2017; Received July 11, 2016; This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/; aDepartment of Psychiatry and Human Behavior, University of California, Irvine, California; bLundbeck LLC, Paramus, New Jersey; cOtsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey; dLundbeck LLC, Deerfield, Illinois, USA; e-mail: [email\u00a0protected]; eOtsuka Pharmaceutical Europe Ltd., Wexham, UK; fLundbeck SAS Issy-les-Moulineaux, Paris, France; fax: +1 949 824 3324; gH. Lundbeck A/S, Valby, Denmark; hDepartment for Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey","institution_ids":["https://openalex.org/I4210086062","https://openalex.org/I4405268153"]},{"raw_affiliation_string":"Accepted January 17, 2017; Received July 11, 2016; This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/; aDepartment of Psychiatry and Human Behavior, University of California, Irvine, California; bLundbeck LLC, Paramus, New Jersey; cOtsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey; dLundbeck LLC, Deerfield, Illinois, USA; e-mail: [email\u00a0protected]; eOtsuka Pharmaceutical Europe Ltd., Wexham, UK; fLundbeck SAS Issy-les-Moulineaux, Paris, France; fax: +1 949 824 3324; gH. Lundbeck A/S, Valby, Denmark; hDepartment for Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060883338","display_name":"Maud Beillat","orcid":"https://orcid.org/0009-0004-2825-1394","observed_orcids":["https://orcid.org/0009-0004-2825-1394"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]},{"id":"https://openalex.org/I2800004676","display_name":"Observatoire de Paris","ror":"https://ror.org/029nkcm90","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I2746051580","https://openalex.org/I2800004676"]}],"countries":["FR","US"],"is_corresponding":false,"raw_author_name":"Maud Beillat","raw_affiliation_strings":["Lundbeck SAS Issy-les-Moulineaux, Paris, France","Accepted January 17, 2017; Received July 11, 2016; This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/; aDepartment of Psychiatry and Human Behavior, University of California, Irvine, California; bLundbeck LLC, Paramus, New Jersey; cOtsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey; dLundbeck LLC, Deerfield, Illinois, USA; e-mail: [email\u00a0protected]; eOtsuka Pharmaceutical Europe Ltd., Wexham, UK; fLundbeck SAS Issy-les-Moulineaux, Paris, France; fax: +1 949 824 3324; gH. Lundbeck A/S, Valby, Denmark; hDepartment for Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lundbeck SAS Issy-les-Moulineaux, Paris, France","institution_ids":["https://openalex.org/I2800004676"]},{"raw_affiliation_string":"Accepted January 17, 2017; Received July 11, 2016; This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/; aDepartment of Psychiatry and Human Behavior, University of California, Irvine, California; bLundbeck LLC, Paramus, New Jersey; cOtsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey; dLundbeck LLC, Deerfield, Illinois, USA; e-mail: [email\u00a0protected]; eOtsuka Pharmaceutical Europe Ltd., Wexham, UK; fLundbeck SAS Issy-les-Moulineaux, Paris, France; fax: +1 949 824 3324; gH. Lundbeck A/S, Valby, Denmark; hDepartment for Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039963290","display_name":"Anna\u2010Greta Nylander","orcid":"https://orcid.org/0000-0002-2089-1256","observed_orcids":["https://orcid.org/0000-0002-2089-1256"]},"institutions":[{"id":"https://openalex.org/I133593841","display_name":"Lundbeck (Denmark)","ror":"https://ror.org/0564cd633","country_code":"DK","type":"company","lineage":["https://openalex.org/I133593841"]},{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["DK","US"],"is_corresponding":false,"raw_author_name":"Anna-Greta Nylander","raw_affiliation_strings":["H. Lundbeck A/S, Valby, Denmark","Accepted January 17, 2017; Received July 11, 2016; This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/; aDepartment of Psychiatry and Human Behavior, University of California, Irvine, California; bLundbeck LLC, Paramus, New Jersey; cOtsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey; dLundbeck LLC, Deerfield, Illinois, USA; e-mail: [email\u00a0protected]; eOtsuka Pharmaceutical Europe Ltd., Wexham, UK; fLundbeck SAS Issy-les-Moulineaux, Paris, France; fax: +1 949 824 3324; gH. Lundbeck A/S, Valby, Denmark; hDepartment for Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lundbeck A/S, Valby, Denmark","institution_ids":["https://openalex.org/I133593841"]},{"raw_affiliation_string":"Accepted January 17, 2017; Received July 11, 2016; This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/; aDepartment of Psychiatry and Human Behavior, University of California, Irvine, California; bLundbeck LLC, Paramus, New Jersey; cOtsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey; dLundbeck LLC, Deerfield, Illinois, USA; e-mail: [email\u00a0protected]; eOtsuka Pharmaceutical Europe Ltd., Wexham, UK; fLundbeck SAS Issy-les-Moulineaux, Paris, France; fax: +1 949 824 3324; gH. Lundbeck A/S, Valby, Denmark; hDepartment for Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076221415","display_name":"Peter Hertel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I133593841","display_name":"Lundbeck (Denmark)","ror":"https://ror.org/0564cd633","country_code":"DK","type":"company","lineage":["https://openalex.org/I133593841"]},{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["DK","US"],"is_corresponding":false,"raw_author_name":"Peter Hertel","raw_affiliation_strings":["H. Lundbeck A/S, Valby, Denmark","Accepted January 17, 2017; Received July 11, 2016; This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/; aDepartment of Psychiatry and Human Behavior, University of California, Irvine, California; bLundbeck LLC, Paramus, New Jersey; cOtsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey; dLundbeck LLC, Deerfield, Illinois, USA; e-mail: [email\u00a0protected]; eOtsuka Pharmaceutical Europe Ltd., Wexham, UK; fLundbeck SAS Issy-les-Moulineaux, Paris, France; fax: +1 949 824 3324; gH. Lundbeck A/S, Valby, Denmark; hDepartment for Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lundbeck A/S, Valby, Denmark","institution_ids":["https://openalex.org/I133593841"]},{"raw_affiliation_string":"Accepted January 17, 2017; Received July 11, 2016; This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/; aDepartment of Psychiatry and Human Behavior, University of California, Irvine, California; bLundbeck LLC, Paramus, New Jersey; cOtsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey; dLundbeck LLC, Deerfield, Illinois, USA; e-mail: [email\u00a0protected]; eOtsuka Pharmaceutical Europe Ltd., Wexham, UK; fLundbeck SAS Issy-les-Moulineaux, Paris, France; fax: +1 949 824 3324; gH. Lundbeck A/S, Valby, Denmark; hDepartment for Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112781444","display_name":"Henrik Steen Andersen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I133593841","display_name":"Lundbeck (Denmark)","ror":"https://ror.org/0564cd633","country_code":"DK","type":"company","lineage":["https://openalex.org/I133593841"]},{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["DK","US"],"is_corresponding":false,"raw_author_name":"Henrik Steen Andersen","raw_affiliation_strings":["H. Lundbeck A/S, Valby, Denmark","Accepted January 17, 2017; Received July 11, 2016; This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/; aDepartment of Psychiatry and Human Behavior, University of California, Irvine, California; bLundbeck LLC, Paramus, New Jersey; cOtsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey; dLundbeck LLC, Deerfield, Illinois, USA; e-mail: [email\u00a0protected]; eOtsuka Pharmaceutical Europe Ltd., Wexham, UK; fLundbeck SAS Issy-les-Moulineaux, Paris, France; fax: +1 949 824 3324; gH. Lundbeck A/S, Valby, Denmark; hDepartment for Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lundbeck A/S, Valby, Denmark","institution_ids":["https://openalex.org/I133593841"]},{"raw_affiliation_string":"Accepted January 17, 2017; Received July 11, 2016; This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/; aDepartment of Psychiatry and Human Behavior, University of California, Irvine, California; bLundbeck LLC, Paramus, New Jersey; cOtsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey; dLundbeck LLC, Deerfield, Illinois, USA; e-mail: [email\u00a0protected]; eOtsuka Pharmaceutical Europe Ltd., Wexham, UK; fLundbeck SAS Issy-les-Moulineaux, Paris, France; fax: +1 949 824 3324; gH. Lundbeck A/S, Valby, Denmark; hDepartment for Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042720237","display_name":"Anna Eramo","orcid":"https://orcid.org/0000-0002-4289-0975","observed_orcids":["https://orcid.org/0000-0002-4289-0975"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]},{"id":"https://openalex.org/I4210150391","display_name":"Lundbeck (United States)","ror":"https://ror.org/04a2yjk98","country_code":"US","type":"company","lineage":["https://openalex.org/I133593841","https://openalex.org/I4210150391"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anna Eramo","raw_affiliation_strings":["Lundbeck LLC, Deerfield, Illinois, USA","Accepted January 17, 2017; Received July 11, 2016; This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/; aDepartment of Psychiatry and Human Behavior, University of California, Irvine, California; bLundbeck LLC, Paramus, New Jersey; cOtsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey; dLundbeck LLC, Deerfield, Illinois, USA; e-mail: [email\u00a0protected]; eOtsuka Pharmaceutical Europe Ltd., Wexham, UK; fLundbeck SAS Issy-les-Moulineaux, Paris, France; fax: +1 949 824 3324; gH. Lundbeck A/S, Valby, Denmark; hDepartment for Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lundbeck LLC, Deerfield, Illinois, USA","institution_ids":["https://openalex.org/I4210150391"]},{"raw_affiliation_string":"Accepted January 17, 2017; Received July 11, 2016; This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/; aDepartment of Psychiatry and Human Behavior, University of California, Irvine, California; bLundbeck LLC, Paramus, New Jersey; cOtsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey; dLundbeck LLC, Deerfield, Illinois, USA; e-mail: [email\u00a0protected]; eOtsuka Pharmaceutical Europe Ltd., Wexham, UK; fLundbeck SAS Issy-les-Moulineaux, Paris, France; fax: +1 949 824 3324; gH. Lundbeck A/S, Valby, Denmark; hDepartment for Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110399927","display_name":"Karina Hansen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]},{"id":"https://openalex.org/I2800004676","display_name":"Observatoire de Paris","ror":"https://ror.org/029nkcm90","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I2746051580","https://openalex.org/I2800004676"]}],"countries":["FR","US"],"is_corresponding":false,"raw_author_name":"Karina Hansen","raw_affiliation_strings":["Lundbeck SAS Issy-les-Moulineaux, Paris, France","Accepted January 17, 2017; Received July 11, 2016; This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/; aDepartment of Psychiatry and Human Behavior, University of California, Irvine, California; bLundbeck LLC, Paramus, New Jersey; cOtsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey; dLundbeck LLC, Deerfield, Illinois, USA; e-mail: [email\u00a0protected]; eOtsuka Pharmaceutical Europe Ltd., Wexham, UK; fLundbeck SAS Issy-les-Moulineaux, Paris, France; fax: +1 949 824 3324; gH. Lundbeck A/S, Valby, Denmark; hDepartment for Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lundbeck SAS Issy-les-Moulineaux, Paris, France","institution_ids":["https://openalex.org/I2800004676"]},{"raw_affiliation_string":"Accepted January 17, 2017; Received July 11, 2016; This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/; aDepartment of Psychiatry and Human Behavior, University of California, Irvine, California; bLundbeck LLC, Paramus, New Jersey; cOtsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey; dLundbeck LLC, Deerfield, Illinois, USA; e-mail: [email\u00a0protected]; eOtsuka Pharmaceutical Europe Ltd., Wexham, UK; fLundbeck SAS Issy-les-Moulineaux, Paris, France; fax: +1 949 824 3324; gH. Lundbeck A/S, Valby, Denmark; hDepartment for Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110050916","display_name":"Dieter Naber","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]},{"id":"https://openalex.org/I4210108711","display_name":"University Medical Center Hamburg-Eppendorf","ror":"https://ror.org/01zgy1s35","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I159176309","https://openalex.org/I4210108711"]}],"countries":["DE","US"],"is_corresponding":false,"raw_author_name":"Dieter Naber","raw_affiliation_strings":["Department for Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany","Accepted January 17, 2017; Received July 11, 2016; This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/; aDepartment of Psychiatry and Human Behavior, University of California, Irvine, California; bLundbeck LLC, Paramus, New Jersey; cOtsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey; dLundbeck LLC, Deerfield, Illinois, USA; e-mail: [email\u00a0protected]; eOtsuka Pharmaceutical Europe Ltd., Wexham, UK; fLundbeck SAS Issy-les-Moulineaux, Paris, France; fax: +1 949 824 3324; gH. Lundbeck A/S, Valby, Denmark; hDepartment for Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department for Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany","institution_ids":["https://openalex.org/I4210108711"]},{"raw_affiliation_string":"Accepted January 17, 2017; Received July 11, 2016; This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/; aDepartment of Psychiatry and Human Behavior, University of California, Irvine, California; bLundbeck LLC, Paramus, New Jersey; cOtsuka Pharmaceutical Development & Commercialization, Inc., Princeton, New Jersey; dLundbeck LLC, Deerfield, Illinois, USA; e-mail: [email\u00a0protected]; eOtsuka Pharmaceutical Europe Ltd., Wexham, UK; fLundbeck SAS Issy-les-Moulineaux, Paris, France; fax: +1 949 824 3324; gH. Lundbeck A/S, Valby, Denmark; hDepartment for Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany","institution_ids":["https://openalex.org/I204250578"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5050834331"],"corresponding_institution_ids":["https://openalex.org/I204250578","https://openalex.org/I4210108711","https://openalex.org/I4405268153"],"apc_list":null,"apc_paid":null,"fwci":2.8883,"has_fulltext":false,"cited_by_count":26,"citation_normalized_percentile":{"value":0.89791049,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"32","issue":"3","first_page":"147","last_page":"154"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10459","display_name":"Sexual function and dysfunction studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aripiprazole-once-monthly","display_name":"aripiprazole once-monthly","score":0.9240000247955322},{"id":"https://openalex.org/keywords/paliperidone-palmitate","display_name":"paliperidone palmitate","score":0.9990000128746033},{"id":"https://openalex.org/keywords/sexual-dysfunction","display_name":"sexual dysfunction","score":0.9620000123977661},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.7379999756813049},{"id":"https://openalex.org/keywords/prolactin-elevation","display_name":"prolactin elevation","score":0.8679999709129333},{"id":"https://openalex.org/keywords/antipsychotic-side-effects","display_name":"antipsychotic adverse effects","score":0.8809999823570251},{"id":"https://openalex.org/keywords/dopamine-d2-receptor-partial-agonist","display_name":"dopamine D2 receptor partial agonist","score":0.8709999918937683},{"id":"https://openalex.org/keywords/dopamine-d2-receptor-antagonists","display_name":"dopamine D2 receptor antagonists","score":0.7429999709129333},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.7630000114440918},{"id":"https://openalex.org/keywords/arizona-sexual-experience-scale","display_name":"Arizona Sexual Experience Scale","score":0.6679999828338623}],"concepts":[{"id":"https://openalex.org/C2780211496","wikidata":"https://www.wikidata.org/wiki/Q411188","display_name":"Aripiprazole","level":3,"score":0.8771087527275085},{"id":"https://openalex.org/C2778093883","wikidata":"https://www.wikidata.org/wiki/Q1137463","display_name":"Sexual dysfunction","level":2,"score":0.7960690259933472},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6185239553451538},{"id":"https://openalex.org/C2908997079","wikidata":"https://www.wikidata.org/wiki/Q27157250","display_name":"Paliperidone Palmitate","level":4,"score":0.6176671385765076},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5998704433441162},{"id":"https://openalex.org/C2779064019","wikidata":"https://www.wikidata.org/wiki/Q66590068","display_name":"Prolactin","level":3,"score":0.5972583293914795},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.5899588465690613},{"id":"https://openalex.org/C58732023","wikidata":"https://www.wikidata.org/wiki/Q770260","display_name":"Partial agonist","level":4,"score":0.5301510095596313},{"id":"https://openalex.org/C2777126507","wikidata":"https://www.wikidata.org/wiki/Q423292","display_name":"Paliperidone","level":4,"score":0.5289901494979858},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.49381574988365173},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.4737176299095154},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.456678569316864},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4561161696910858},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.45050644874572754},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.19448554515838623},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.16457822918891907},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.12666383385658264}],"mesh":[{"descriptor_ui":"D000068180","descriptor_name":"Aripiprazole","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000068180","descriptor_name":"Aripiprazole","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000068882","descriptor_name":"Paliperidone Palmitate","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000068882","descriptor_name":"Paliperidone Palmitate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011388","descriptor_name":"Prolactin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012735","descriptor_name":"Sexual Dysfunction, Physiological","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1097/yic.0000000000000168","doi":"https://doi.org/10.1097/yic.0000000000000168","is_oa":true,"landing_page_url":"https://doi.org/10.1097/yic.0000000000000168","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:28252452","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28252452","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International clinical psychopharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5378005","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5378005/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Int Clin Psychopharmacol","raw_type":"Text"},{"id":"pmh:oai:escholarship.org:ark:/13030/qt5xf686sk","doi":null,"is_oa":true,"landing_page_url":"https://escholarship.org/uc/item/5xf686sk","pdf_url":null,"source":{"id":"https://openalex.org/S4306400115","display_name":"eScholarship (California Digital Library)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2801248553","host_organization_name":"California Digital Library","host_organization_lineage":["https://openalex.org/I2801248553"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"International Clinical Psychopharmacology, vol 32, iss 3","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1097/yic.0000000000000168","doi":"https://doi.org/10.1097/yic.0000000000000168","is_oa":true,"landing_page_url":"https://doi.org/10.1097/yic.0000000000000168","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320324177","display_name":"Otsuka Pharmaceutical","ror":"https://ror.org/013k5y296"},{"id":"https://openalex.org/F4320327918","display_name":"H. Lundbeck A/S","ror":"https://ror.org/0564cd633"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W1807043087","https://openalex.org/W1966949437","https://openalex.org/W1979372409","https://openalex.org/W1987902149","https://openalex.org/W1992236835","https://openalex.org/W2039549833","https://openalex.org/W2071033221","https://openalex.org/W2071057975","https://openalex.org/W2086694288","https://openalex.org/W2088866491","https://openalex.org/W2090569570","https://openalex.org/W2107201157","https://openalex.org/W2149639459","https://openalex.org/W2157910519","https://openalex.org/W2162630389","https://openalex.org/W2164182651","https://openalex.org/W2165397843","https://openalex.org/W2165836162"],"related_works":["https://openalex.org/W1987902149","https://openalex.org/W1978123597","https://openalex.org/W4238421985","https://openalex.org/W2768500454","https://openalex.org/W3171305253","https://openalex.org/W4407989563","https://openalex.org/W75489403","https://openalex.org/W1996814532","https://openalex.org/W2129975487","https://openalex.org/W7096421372"],"abstract_inverted_index":{"Sexual":[0,64,67],"dysfunction,":[1],"a":[2,22,31,46,131,181],"common":[3],"side":[4],"effect":[5],"of":[6,18],"antipsychotic":[7],"medications,":[8],"may":[9],"be":[10],"partly":[11],"caused":[12],"by":[13],"dopamine":[14,32,47],"antagonism":[15],"and":[16,39,70,108,153,163,187],"elevation":[17,189],"prolactin.":[19],"In":[20,172],"QUALIFY,":[21],"randomized":[23],"study,":[24],"aripiprazole":[25],"once-monthly":[26],"400":[27,85,149,192],"mg":[28],"(AOM":[29],"400),":[30],"D2":[33,48],"receptor":[34,49],"partial":[35],"agonist,":[36],"showed":[37],"noninferiority":[38],"subsequent":[40],"superiority":[41],"versus":[42,86,193],"paliperidone":[43],"palmitate":[44],"(PP),":[45],"antagonist,":[50],"on":[51,177],"the":[52,137],"Heinrichs-Carpenter":[53],"Quality-of-Life":[54],"Scale":[55],"(QLS)":[56],"in":[57,99,136,160,195],"patients":[58,109,117,167,179],"with":[59,83,147,155,190],"schizophrenia":[60],"aged":[61,110],"18-60":[62],"years.":[63],"dysfunction":[65,80,121,186],"(Arizona":[66],"Experience":[68],"Scale)":[69],"serum":[71],"prolactin":[72,144,188],"levels":[73],"were":[74,81],"also":[75],"assessed.":[76],"Odds":[77],"for":[78,184],"sexual":[79,120,185],"lower":[82,182],"AOM":[84,148,191],"PP":[87,156,194],"[week":[88],"28":[89],"adjusted":[90],"odds":[91],"ratio":[92],"(95%":[93],"confidence":[94],"interval),":[95],"0.29":[96],"(0.14-0.61);":[97],"P=0.0012]":[98],"men":[100,162],"[0.33":[101],"(0.13-0.86);":[102],"P=0.023],":[103],"women":[104],"[0.14":[105],"(0.03-0.62);":[106],"P=0.0099],":[107],"18-35":[111],"years":[112],"[0.04":[113],"(<0.01-0.34);":[114],"P=0.003].":[115],"Among":[116],"shifting":[118],"from":[119],"at":[122,126],"baseline":[123],"to":[124,174],"none":[125],"week":[127],"28,":[128],"there":[129],"was":[130],"trend":[132],"toward":[133],"greater":[134,175],"improvement":[135,176],"QLS":[138],"total":[139],"score.":[140],"The":[141],"mean":[142],"(SD)":[143],"concentrations":[145],"decreased":[146],"[-150.6":[150],"(274.4)":[151],"mIU/l]":[152,159],"increased":[154],"[464.7":[157],"(867.5)":[158],"both":[161],"women.":[164],"Six":[165],"PP-treated":[166],"experienced":[168],"prolactin-related":[169],"adverse":[170],"events.":[171],"addition":[173],"QLS,":[178],"had":[180],"risk":[183],"QUALIFY.":[196]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2017-03-16T00:00:00"}